MNOV on Nasdaq

MEDICINOVA INC

The MediciNova logo is a registered trademark of MediciNova, Inc. All other product and company names are registered trademarks or trademarks of their respective companies.3 From its latest annual report

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with Can Fite Biopharma, Selecta Biosciences (United States) or America Great Health, or pick any stock.

  • TickerMNOV on Nasdaq1
  • IndustryPharmaceutical Preparations1
  • HeadquartersLa Jolla, California1
  • Incorporated inDE2
  • Business address4275 Executive Square, Suite 300, La Jolla, Ca 920372
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

The MediciNova logo is a registered trademark of MediciNova, Inc. All other product and company names are registered trademarks or trademarks of their respective companies.3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

-3242.5%Operating margin4
-2928.8%Net margin4
-28.9%Return on equity4
-$9.8MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Research and development100¢$6.7M
  • Income tax0¢$6.0K

Out of $409.7K in revenue.4 The company lost money this year.

Financial statements

Revenue564$409.7K in 2025−90% since 2021
0$2.0M$4.0M$6.0M2021: $4.0M$4.0M20212023: $1.0M$1.0M2023−75%2025: $409.7K$409.7K2025−59%
Operating income785964-$13.3M in 2025−5% since 2019
-$15.0M-$10.0M-$5.0M02019: -$14.0M-$14.0M20192020: -$14.2M-$14.2M2020+1%2021: -$10.2M-$10.2M2021−28%2022: -$14.6M-$14.6M2022+43%2023: -$9.9M-$9.9M2023−32%2024: -$12.7M-$12.7M2024+28%2025: -$13.3M-$13.3M2025+5%
Net income785964-$12.0M in 2025−7% since 2019
-$15.0M-$10.0M-$5.0M02019: -$12.9M-$12.9M20192020: -$13.9M-$13.9M2020+7%2021: -$10.1M-$10.1M2021−27%2022: -$14.1M-$14.1M2022+39%2023: -$8.6M-$8.6M2023−39%2024: -$11.0M-$11.0M2024+29%2025: -$12.0M-$12.0M2025+9%

Every line of the income statement as filed: the last 2 fiscal years, latest first.4

Period ending2025-12-312024-12-31
Revenues$409.7K
Cost of services$378.6K
Research, development and patents$7.2M$7.2M
General and administrative$6.2M$5.5M
Total operating expenses$13.7M$12.7M
Operating loss-$13.3M-$12.7M
Interest income$1.3M$1.7M
Other expense, net-$12.8K-$39.5K
Loss before income taxes-$12.0M-$11.0M
Income tax expense-$6.0K-$5.5K
Net loss-$12.0M-$11.0M
Basic net loss per common share-$0.24-$0.23
Diluted net loss per common share-$0.24-$0.23
Shares used to compute basic net loss per common share49.1M shares49.0M shares
Shares used to compute diluted net loss per common share49.1M shares49.0M shares
Foreign currency translation adjustments$8.0K-$17.1K
Comprehensive loss-$12.0M-$11.1M

Compare MEDICINOVA INC with another company

Leadership

Who has led MEDICINOVA INC, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Yuichi Iwaki2006–now

President

  1. Yuichi Iwaki2008–now

Chief financial officer

  1. Shintaro Asako2006–2010
  2. Michael Denis Coffee2011
  3. Michael J. Gennaro2011
  4. Yuichi Iwaki2013
  5. Ryan J. Selhorn2016
  6. Carla Reyes2018
  7. Edward C. Stepanow Jr.2020
  8. Douglas Paulin2021
  9. Jason J. Kruger2022
2010201520202025
Board members and other officers (26)

Timeline

  1. Jan 6, 2006New chief executive Yuichi Iwaki becomes CEO12

Filings

113 filings to the SEC since October 2021: 6 annual reports, 15 quarterly reports, 18 major events, 38 insider forms, 2 large holders, 34 other. The latest 20:

  1. Sep 29, 20264 EDGAR
  2. Sep 29, 2026SCHEDULE 13D/A EDGAR
  3. Sep 28, 20268-K EDGAR
  4. Sep 2, 20268-K EDGAR
  5. Aug 19, 20268-K EDGAR
  6. Aug 13, 202610-Q EDGAR
  7. Jun 25, 20264 EDGAR
  8. Jun 25, 20264 EDGAR
  9. Jun 25, 20264 EDGAR
  10. Jun 24, 20268-K EDGAR
  11. May 14, 202610-Q EDGAR
  12. Apr 29, 2026ARS EDGAR
  13. Apr 29, 2026DEFA14A EDGAR
  14. Apr 29, 2026DEF 14A EDGAR
  15. Apr 20, 2026PRER14A EDGAR
  16. Apr 17, 2026PRE 14A EDGAR
  17. Mar 10, 202610-K EDGAR
  18. Feb 20, 20268-K EDGAR
  19. Jan 20, 20264 EDGAR
  20. Jan 20, 20264 EDGAR

The 113 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

5 open-market trades by officers, directors and large owners since October 2021: 0 buys and 5 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Sep 25, 20263D Opportunity Master FundSale640,000$2.70$1.7MForm 4
Nov 28, 2022Nagao HidekiDirectorSale6,754$2.25$15.2KForm 4
Nov 22, 2022Nagao HidekiDirectorSale218$2.13$464Form 4
Nov 21, 2022Nagao HidekiDirectorSale5,365$2.18$11.7KForm 4
Nov 17, 2022Nagao HidekiDirectorSale309$2.18$674Form 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 29. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Essex Woodlands Management, Inc.1,105,941$1.5M0.6%No change
BlackRock, Inc.752,091$992.8K0.0%+46,137
Citigroup Inc635,715$839.1K0.0%No change
Vanguard Capital Management LLC609,052$803.9K0.0%−1,987
Geode Capital Management, LLC539,312$712.1K0.0%−4,531
Vanguard Fiduciary Trust Co282,608$373.0K0.0%+1,987
UBS Group AG222,200$293.3K0.0%No change
Renaissance Technologies LLC205,400$271.1K0.0%+15,500
State Street Corp193,698$255.7K0.0%No change
Northern Trust Corp143,665$189.6K0.0%+10,502
Bank of New York Mellon Corp78,277$103.3K0.0%No change
Charles Schwab Investment Management Inc71,506$94.4K0.0%No change
Bridgeway Capital Management, LLC56,031$74.0K0.0%No change
SBI Securities Co., Ltd.51,479$68.0K0.0%+6,603
Dimensional Fund Advisors LP50,552$66.7K0.0%No change
Barclays PLC42,806$56.5K0.0%−120,094
Schonfeld Strategic Advisors LLC36,157$47.7K0.0%−219
Susquehanna International Group, Llp26,752$35.3K0.0%−17,174
Jane Street Group, LLC15,818$20.9K0.0%−71,267
Vanguard Global Advisers, LLC15,599$20.6K0.0%No change
Two Sigma Investments, LP13,526$17.9K0.0%−16,283
Bank Of America Corp /de/13,159$17.4K0.0%−21,200
Focus Partners Advisor Solutions, LLC10,000$13.2K0.0%New
Morgan Stanley2,000$2.6K0.0%No change
Northwestern Mutual Wealth Management Co305$4030.0%No change

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48